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We have examined the sub-type specific functions within the MH2 domain of the SMAD-family
of transcription factors and found that our novel algorithm, called “Sequence Harmony”, has
a high specificity for identification of sites important for the functional differences. For the
SMAD MH2 domain, 40 sub-type specific functional sites are predicted, which in the structure
form clusters of similar function, i.e. for receptor binding, co-repressor binding and binding
to transcription factors. From these clusters, putative functions were assigned to eleven out of
fourteen predicted functional sites with unknown function. We propose these fourteen sites of
unknown function as interesting candidates for further (experimental) investigation.
1 Introduction
Protein families and sub-families separated on the basis of functional properties.1, 2 It is
therefore not surprising that a fair number of methods are in use for the comparison of
amino-acid composition at different positions between groups of proteins from different
families and/or sub-types.3, 4 It is surprising, however, that apparently in the vast majority
of those studies, relatively little thought has been given to the underlying formalism of
sequence comparison. Starting from a multiple sequence alignment (MSA) of the proteins
of interest, the aim is to identify sites that are possibly conserved within a group, but
certainly different between the groups.
Current practice seems to focus on sites that are conserved in both groups, but still
different between them,3 thereby excluding sites that are not totally conserved but never-
theless different between groups. This may not seem a serious problem at first hand, but
let us consider an example of proteins that bind a certain receptor (the ‘binders’) and those
that don’t (the ‘non-binders’). Certainly, one can expect sites that are crucial for binding
to be conserved in the group of ‘binders’. To exclude binding, on the other hand, several
of many reasons may suffice and it seems imprudent to expect those sites to be conserved
as well in the group of ‘non-binders’. If the binders also interact with different, related,
receptors, also the restriction to sites conserved in the group of ’binders’ may not be a sen-
sible one. Relative entropy is a measure for the difference in information content between
both distributions of amino acid types.5 Unfortunately, for those sites that interest us the
relative entropy is degenerate. We will introduce an alternative similarity measure named
Sequence Harmony for comparison of groups of sequences.
We have applied our method to the interactions of the SMAD proteins with the cell-
membrane associated receptors TBβRI and BMPRI. The SMAD-TBβRI and SMAD-BMPRI
interactions are relatively well-studied6 and provide a good background of experimental
data on which to validate our method.
* KAF and WP acknowledge financial support from Biorange/Netherlands Bioinformatics Centre.
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2 Theory
Commonly used methods for sequence comparison from multiple sequence alignments
share several drawbacks. As an alternative solution, we propose:
SHABi =
∑
x
pAi,x log
pAi,x
pAi,x + p
B
i,x
(1)
where the ‘relative entropy’ of group A is calculated relative to the sum of the probabilities
of both groups (pA + pB). This function operates opposite to the relative entropy; zero for
maximally different sites and one for sites with identical distributions. It is therefore that
we coin this measure Sequence Harmony (SH) as it indicates the amount of correspondence
of amino acid composition between two groups of sequences.
3 Results
Protein sequences for the R-SMADs were collected using the NCBI query for sequence
retrieval (www.ncbi.nih.gov), yielding 32 sequences: 17 BR-SMADs and 15 AR-SMADs,
including that of the SMAD2-MH2 structure (PDB-ID: 1KHX7), and aligned using PSI-
Praline (www.ibivu.cs.vu.nl/programs/pralinewww).8 From the alignment obtained, the
MH2 domain was selected for further analysis, and divided according into two subgroups,
AR-SMADs (binding TBβRI) and BR-SMADs (binding BMPRI).
Sequence Harmony was calculated using Eq. 1 for AR-SMADs and BR-SMADs at all po-
sitions in the alignment, see Figure 1. Relatively few sites are completely non-harmonious
(32 SH=0) whereas the vast majority are overall conserved (137 SH=1), and the remain-
ing are intermediate (44 0<SH<1). Furthermore, the low harmony sites are not spread
completely randomly along the sequence, but clusters can be seen of up to about five low
harmony sites spread over a sequence stretch of up to about ten residues.
Out of the 40 low harmony sites, 26 have a known function (65%), and for the 32 non-
harmonious sites, 22 have a known function (69%). Of the 171 remaining high-harmony
Figure 1. Sequence harmony for AR vs. BR-SMADs plotted along the sequence of the MH2 domain of SMADs.
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sites, on the other hand, to the best of our knowledge no other specific sites have been
identified as important for receptor binding specificity.
Figure 2 shows the SMAD2-MH2 domain colored by Sequence Harmony. The distri-
bution of non-harmonious sites (red) is far from random, and in addition, the low harmony
sites (orange) cluster along with them. In fact, we can identify a limited number of clus-
tered regions high in low harmony sites, which are summarized in Table 1. The sites of
known function in most clusters, allow us to assign putative functions to the remaining
sites of unknown function.
Three of these clusters (#4, 5 and 7) are associated with receptor binding. The second-
largest cluster (#2) is associated with c-Ski/SnoN interactions, and consists of a group of
six largely non-sequentially low harmony sites. In addition, all sidechains point in the
same general direction, forming a putative interaction surface. Three clusters (#1, 3 and
6) are associated with FAST1, Mixer and/or SARA binding. FAST1, Mixer share a SMAD
interaction motif which is similar to that of SARA and have been shown to compete for
binding to AR-SMADs.10 Here as well, the sidechains form a putative interaction surface.
The surface-patch formed by the sidechains of the largest cluster, #1, is less regular. The
two smallest clusters (#8 and 9) are formed of sites of unknown function. In the structure
of the functional trimeric form of the SMAD2-MH2 domain residues of cluster #8 are close
to several sites of known function across the protein interface.
4 Discussion & Conclusion
Sites of low Sequence Harmony correspond very specifically to functionally relevant sites
in the SMAD-MH2 domain, with a very sharp separation between conserved positions
Figure 2. Sequence Harmony for AR-SMADs versus BR-SMADs colour-coded onto a SMAD2-MH2 structure
(1KHX), cf. the values in Figure 1. Non-harmonious (SH zero) is red and labeled with residue names and num-
bers, maximal harmony (SH one) is white, intermediate values are rainbow colours from red to light blue.
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Cluster Sites Ref. Function
1 360, 364-366, 368, 392, 400, 407, 410 7,11,10,12 FAST1, Mixer, SARA, ?
2 294, 295, 297-298, 308, 309, 334, 337 7,13 c-Ski/SnoN, ?
3 267, 269, 272, 273, 443 7 SARA, ?
4 284, 323-325, 327 6,14 TβRI/BMPRI/ALK1/2
5 460-463 12 TβRI/BMPRI/ALK1/2
6 341, 346, 381 7,10 SARA/Mixer
7 427,430 12 TβRI/BMPRI/ALK1/2
8 354,378 - ?
9 440 - ?
Table 1. Structural clusters of low harmony sites (cf. Figure 2) and their respective known functions.
(which are the majority) and those that show a clear difference between the TGF-β and
the BMP-binding sub-types. The Sequence Harmony scale corresponds to an intuitive in-
terpretation of the differences in sequence composition and can be interpreted as sites that
are more or less likely to be of functional importance. From the available experimental ev-
idence in literature, it is difficult to identify false positive predictions, and almost no direct
evidence is present to discriminate true from false negatives.
We have identified 13 sites of low Sequence Harmony in the SMAD-MH2 domain of un-
verified function and hereby suggest these as promising candidates for further elucidation
of their function in determining the specificity of the TGF-β and BMP signalling pathways.
Specifically, it would be very interesting to confirm (or rebuke) the putative functional roles
we assigned to these sites of unknown function based on their proximity to low harmony
sites of known function.
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